FDA Warns Consumers About Skin-Whitening Injectables

A growing number of injectable skin-whitening products are available to consumers through online retailers and other channels, FDA says in an update cautioning the public that such products could pose "significant" safety risks. The agency singles out Flawless Beauty, LLC, which has been subject to recent enforcement activity, including product seizure by U.S. Marshals, but continues to market questionable skin-whitening products with aggressive claims.

FDA is warning the public about the potential dangers of injectable skin-whitening products in a Sept. 2 Consumer Update, calling one company out in particular for its contribution to the concerning trend.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight

US Fragrance Firms Should Identify Domestic, Non-Tariff Sources Now – Fragrance House CEO

Firms in the US facing tariff costs should identify US-based, non-tariff sources and lobby local government officials and DC when foreign-sourced ingredients cannot be substituted in the US.

Trump Order To Improve Making More Drugs Available OTC Puts Wind Behind Petros’ ACNU Sails

 

Petros will incorporate into its platform an analytics firm’s automated document capture and authentication system leveraging its global ID library to verify identity and eligibility of consumers accessing the self-selection process for an ACNU switch.

PharmaSGP Targets More Of The Same As It Outperforms OTC Market

 
• By 

Germany-based firm grew three-times faster than the OTC pharmacy market in 2024 and is hoping to continue this momentum in 2025.